Active ingredientAlfacalcidolCat. No. P-A072-001CAS 41294-56-8Family · Pharmaceutical analytical standards
Alfacalcidol
A synthetic vitamin D analogue (1-alpha-hydroxycholecalciferol), synthesised in the early 1970s and in use since 1978 for bone and calcium disorders in chronic kidney disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It already carries the 1-alpha-hydroxyl group and is converted in the liver into calcitriol, the active form of vitamin D: this is why it works even when the kidneys can no longer activate vitamin D.
Go to the active ingredient →Active ingredientAlfacalcidolCat. No. P-A072-001CAS 41294-56-8
Pharmacopoeial impurityAlfacalcidol EP Impurity ACat. No. P-A072-002CAS 65445-14-9
Pharmacopoeial impurityAlfacalcidol EP Impurity BCat. No. P-A072-003CAS 63181-13-5
Pharmacopoeial impurityAlfacalcidol EP Impurity CCat. No. P-A072-004CAS 82266-85-1
Isotopically labelledAlfacalcidol-d7Cat. No. P-A072-005
Impurity1-Hydroxyprevitamin D3Cat. No. P-A072-006CAS 41461-13-6
ImpurityAlfacalcidol Impurity 1Cat. No. P-A072-007CAS 104651-70-9
ImpurityAlfacalcidol Impurity 2Cat. No. P-A072-008
ImpurityAlfacalcidol Impurity 3Cat. No. P-A072-009
ImpurityAlfacalcidol Impurity 4Cat. No. P-A072-010CAS 203261-58-9
ImpurityAlfacalcidol Impurity 5Cat. No. P-A072-011No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceAlfacalcidol CRSEDQM code A0325450Family AlfacalcidolImpurityAlfacalcidol impurity B CRSEDQM code Y0002296Family AlfacalcidolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.